$ Value
$0
Shares
16,650
Price
$0
Filed
Feb 13
Insider
Name
Garfield Alastair
Title
Chief Scientific Officer
CIK
0002027261
Roles
Transaction Details
Transaction Date
2026-02-11
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
16,650
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. | The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. | The stock options were granted on February 11, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Filing Info
Garfield Alastair's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | RYTM | A | $0 |
| 2026-02-11 | RYTM | A | $0 |
| 2026-02-01 | RYTM | M | — |
| 2026-02-01 | RYTM | F | $221K |
| 2026-02-01 | RYTM | M | $0 |
| 2025-07-02 | RYTM | ▼ | $85K |
| 2025-07-02 | RYTM | ▼ | $388 |
| 2025-07-01 | RYTM | M | — |
| 2025-07-01 | RYTM | M | $0 |
Other Insiders at RYTM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
German Christopher Paul
Corporate Controller & CAO
|
— | $503K | 2026-03-04 |
| Mathers Edward T | — | — | 2026-03-12 |
| Popovits Kimberly J | — | — | 2026-04-01 |
|
Meeker David P
President and CEO
|
— | — | 2026-02-11 |
|
Smith Hunter C
Chief Financial Officer
|
— | $2.2M | 2026-03-02 |
|
Mazabraud Yann
EVP, Head of International
|
— | — | 2026-04-01 |
|
Lee Jennifer Kayden
EVP, Head of North America
|
— | — | 2026-02-11 |
|
Cramer Pamela J.
Chief Human Resources Officer
|
— | — | 2026-02-11 |
|
Shulman Joseph
Chief Technical Officer
|
— | — | 2026-02-11 |
|
Garfield Alastair
Chief Scientific Officer
|
— | — | 2026-02-11 |